Stay updated on PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial

Sign up to get notified when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T00:56:35.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T17:19:42.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T07:39:39.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T04:54:46.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:58:58.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the detailed description of a Phase 3 clinical trial for PH94B nasal spray aimed at treating social anxiety disorder. The only notable addition is the mention of the revision number, which does not alter the core information.
    Difference
    42%
    Check dated 2025-04-16T02:07:45.000Z thumbnail image

Stay in the know with updates to PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.